All of this is associated, according to the available evidence, with a greater burden of vascular pathology, neuroinflammation and disorder of brain insulin signaling, as well as alterations in certain neurotransmitter systems such as the dopaminergic and serotonin pathways in patients with diabetes that contribute to cognitive impairment and probably to its clinical profile[29–31]. The gene discussed is INS; the disease is diabetes mellitus.